Room for improvement? A survey of the methods used in systematic reviews of adverse effects

Ref ID 432
First Author S. Golder
Journal BMC MEDICAL RESEARCH METHODOLOGY
Year Of Publishing 2006
URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402311/
Keywords • Harms
• Sponsorship bias
• Risk of bias
• Low reporting quality
Problem(s) • Reliance on randomised controlled trials for harms / safety data
• Search strategy not provided
• Conflict of interest statement or disclosures for review authors missing
• Financial conflicts of interest of review authors
• No quality assessment undertaken or reported
Article Type Empirical
Article Subtype Cross-sectional survey/Methodological systematic review
First Author Country United Kingdom
Aim To assess the methodological process used in systematic reviews of adverse effects published in the Database of Abstracts of Reviews of Effects and the Cochrane Database of Systematic Reviews between 1994 and 2005.
Level of Investigation Descriptive
Summary of Findings 48% of included reviews provided information on the source of funding. Very few (5%) provided sufficient information to reproduce the literature search. Of the reviews that did report financial support 85 were independent sources, 32 could represent a conflict of interest (largely a drug manufacturer), and 6 said they received no financial support. 63% of reviews sought to include studies that compared the intervention with a control, and 28% of reviews limited themselves to data from randomised controlled trials. Less than half (41%) of the reviews specified assessment of the quality of the included studies in the methods section, or alluded to it by describing in the methods data extraction that included indicators of study quality.
Number of systematic reviews included 256
Number of eligible systematic reviews assessed 3635
Treatment impacted No
Treatment impacted description
Interpretation impacted Not Applicable
Interpretation impacted description